Clinical Trial Update: Long-term Efficacy and Safety of HMS5552 in T2DM Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting long-term efficacy and safety of HMS5552 in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HMS5552

Snippet

Sponsor: Hua Medicine Limited | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED